T 1629/23 (Resolving genome fractions/VERINATA HEALTH) of 20.02.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T162923.20250220
- Date of decision
- 20 February 2025
- Case number
- T 1629/23
- Petition for review of
- -
- Application number
- 18186518.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Resolving genome fractions using polymorphism counts
- Applicant name
- Verinata Health, Inc.
- Opponent name
- Roche Diagnostics GmbH
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(1)European Patent Convention Art 56European Patent Convention Art 87Rules of procedure of the Boards of Appeal 2020 Art 012(3)Rules of procedure of the Boards of Appeal 2020 Art 012(5)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Main request - priority (no)
Main request - inventive step (no)
Auxiliary requests - admittance (no) - Catchword
- -
- Cited cases
- T 2598/12T 0694/15T 0816/16T 1919/17T 2115/17T 0261/19T 1913/19T 2360/19T 1006/21T 1220/21
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.